4
Changes in Ownership
Outlook Therapeutics, Inc. Filed Acc 0001209191-22-038985
CEO and President bought 19,925 shares at $1.06 ($21,121)
From the SEC's structured data for this filing
Trades in this filing
Table I: Non-derivative
| Insider | Date | Transaction | Shares | Price | Value | Owned after | D/I |
|---|---|---|---|---|---|---|---|
| TRENARY C RUSSELL III CEO and President | 2022-06-21 | Purchase | +19,925 | $1.06 | $21,121 | 54,925 | D: show line 1 in the form |
| Open-market purchases · 19,925 sh · avg $1.06 · $21,121 | |||||||
Loading xslF345X03/doc4.xml…